Cite
HARVARD Citation
Kvien, T. et al. (n.d.). THU0393 Secukinumab provides sustained reduction in fatigue in patients with ankylosing spondylitis through 3 years: long-term results of two randomised double-blind placebo-controlled phase 3 studies. Annals of the rheumatic diseases. pp. 355-356. [Online].